FRZB is Regulated by the Transcription Factor EGR1 and Inhibits the Growth and Invasion of Triple-Negative Breast Cancer Cells by Regulating the JAK/STAT3 Pathway [0.03%]
转录因子EGR1通过调节JAK/STAT3信号通路抑制三阴性乳腺癌细胞的增殖和侵袭从而调控FRZB基因的表达
Haixia Liu,Yu Mei,Xiaoshan Ma et al.
Haixia Liu et al.
Background: To explore the expression of frizzled related protein (FRZB) in triple-negative breast cancer (TNBC) and role of FRZB in TNBC cell growth and invasion. ...
Monitoring Breast Cancer Care Quality at National and Local Level Using the French National Cancer Cohort [0.03%]
利用法国全国癌症队列监测全国和地方水平的乳腺癌护理质量
Sophie Houzard,Emilie Courtois,Christine Le Bihan Benjamin et al.
Sophie Houzard et al.
Purpose: The French National Cancer Institute has developed, in partnership with the French National Authority for Health, breast cancer-specific Care Quality, and Safety Indicators (BC QIs). With regard to the most commo...
Effect of Electroacupuncture Based on ERAS for Preoperative Anxiety in Breast Cancer Surgery: A Single-Center, Randomized, Controlled Trial [0.03%]
基于ERAS的电针对于乳腺癌手术围术期焦虑的影响：单中心随机对照试验
Qiu-Yu Tong,Ran Liu,Yuan Gao et al.
Qiu-Yu Tong et al.
Background: To evaluate the effect of electroacupuncture (EA) based on enhanced recovery after surgery on preoperative anxiety in patients undergoing breast cancer surgery. ...
Randomized Controlled Trial
Clinical breast cancer. 2022 Oct;22(7):724-736. DOI:10.1016/j.clbc.2022.04.010 2022
Value of Long-term Follow-up in Surgically Excised Lesions of Uncertain Malignant Potential in the Breast - Is 5 Years Necessary? [0.03%]
乳腺不确定恶性潜能的手术切除病变长期随访的价值-需要5年吗？
Grace Hennessy,Michael R Boland,Marie Bambrick et al.
Grace Hennessy et al.
Introduction: B3 lesions are a heterogeneous group of breast lesions of uncertain malignant potential which usually require excision. The aim was to assess the efficacy of 5 years routine radiological or clinical follow-u...
Plasma Profile of Immune Determinants Predicts Pathological Complete Response in Locally Advanced Breast Cancer Patients: A Pilot Study [0.03%]
血浆免疫指标谱系可预测局部晚期乳腺癌患者病理完全缓解：一项概念验证研究
Rosalba Miceli,Chunmei Cao,Nicolai N Maolanon et al.
Rosalba Miceli et al.
Background: Complex interactions between cancer and the immune system have an impact on disease progression and therapeutic response. Our objective was to evaluate whether circulating immune-related determinants are assoc...
Differential Expression of the Genes Coding for Adipokines and Epithelial Cell Polarity Components in Women With Low and High Mammographic Density [0.03%]
低乳腺密度和高乳腺密度女性中脂肪细胞因子及上皮细胞极性成分编码基因的差异表达
Danila Coradini,Federico Ambrogi
Danila Coradini
Background: Women with extensive mammographic density (MD) are more likely to develop breast cancer than women with low MD because of a high epithelial component associated with a high proportion of stromal cells. To eluc...
Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis [0.03%]
癌症干细胞和循环肿瘤细胞促进乳腺癌转移
RamaRao Malla,Kiran Puvalachetty,Rahul K Vempati et al.
RamaRao Malla et al.
Breast cancer (BC) is a highly metastatic, pathological cancer that significantly affects women worldwide. The mortality rate of BC is related to its heterogeneity, aggressive phenotype, and metastasis. Recent studies have highlighted that ...
A Comparative Study of Drain in Oncoplastic Breast Conserving Surgery (Therapeutic Mammaplasty and Chest Wall Perforator Flap Partial Breast Reconstruction) vs. Mastectomy [0.03%]
乳腺肿瘤整形保乳手术（治疗性乳房成形术和胸壁血管皮瓣部分乳房重建）与乳房切除术的比较研究
Ian Samir Yep Manzano,Amit Agrawal
Ian Samir Yep Manzano
Background: Increasingly, breast surgery is same day or 23-hour day-case surgery. Discharge criteria need to ensure patient safety outside hospital. We explore some of the evolving day-case factors in oncoplastic breast s...
An Analysis of the Evidence Informing Clinical Practice Guidelines in the Management and Treatment of Breast Cancer [0.03%]
关于乳腺癌管理与治疗的临床实践指南证据的分析
Kelsey Snider,Ty Moore,Corbin Walters et al.
Kelsey Snider et al.
Objective: The aim of this study was to assess the methodological quality and accuracy of reporting within systematic reviews (SRs) that provide evidence to form clinical practice guidelines (CPGs) in the management and t...
Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment Strategies [0.03%]
激素受体(HR)弱阳性、HER2阴性乳腺癌的临床病理特征及治疗策略现状分析
Johanna E Poterala,Thomas Havighurst,Kari Braun Wisinski
Johanna E Poterala
Background: Hormone receptor (HR) and human epidermal growth factor receptor-2 (HER2) status is critical for determining management of breast cancer. Previous reports of small cohorts with weak HR-positive (HR+)/HER2-nega...